• India has the highest number of USFDA-approved plants outside USA 

  • Indian healthcare market is the world's second-fastest growing with a market of US$65 billion growing at 15% CAGR 

  • India's medical tourism sector is growing at a rate of 30%, making it a $2 billion industry by 2015. 

Overview

The Tata Capital Healthcare Fund (TCHF) targets long-term capital appreciation through private equity growth-capital investments in healthcare companies that have a significant proportion of their operations in or revenues from India.

The Funds investment strategy is based on taking advantage of opportunities in the high growth Indian healthcare sector over the next decade. The Fund targets significant minority positions in portfolio companies with Board representation and other significant shareholder rights. The typical deal size for TCHF is in the range of US$5-15 mn and the average holding period is five years.

Healthcare in India is a large service sector in terms of revenues and is amongst the fastest growing healthcare markets worldwide. From a market size of US$99 billion in 2015 (as per PwC report), the Indian healthcare sector is estimated to grow at 12% CAGR over the next decade driven by increasing per capita disposable income, rising urbanization and growing health awareness, rapidly shifting disease pattern from acute to chronic and growth in domestic healthcare infrastructure.

Based on the above outlook, the Fund pursues an investment strategy that is predicated on high growth consumption and competency themes.

 

 

 

Tata Capital Private Equity has engaged CAMS - a professionally managed, institutionally owned and SEBI regulated IT services solution partner to provide investor related accounting services.

To log in to your CAMS Online Account, click here

 

Fund in the news
  • Tata Capital Healthcare Fund plans Fund II in 2016 Know more
  • Tata Capital Healthcare Fund looking to raise second fund next year Know more
Portfolio News & Articles
  •   Phase I/II trials for DFU potential drug successful: NovaLead Know more
  •   NovaLead Pharma to launch drug for diabetic foot ulcer Know more
People